Dr Lindley is a senior advisor to the Singapore Institute of Food and Biotechnology Innovation (SIFBI) at ASTAR and also advises a number of startups and Venture Capital funds. He was the founding director of the Biotransformation Innovation Platform that was later integrated into SIFBI. Prior to this he was a senior research director at CNRS, France where he held the position of Executive Director of the LISBP laboratory in Toulouse from 2004-2015 (now known as the Toulouse Biotechnology Institute). He also directed the Toulouse Genopole (2012-2016) and before that teh technology transfer structure (CRITT-BioIndustries). He did his PhD in microbiology in the UK working on methanol and hydrocarbon metabolism before obtaining a Royal Society Fellowship Award in 1984, enabling his tranfser to France where he built his research career within the CNRS laboratories in Toulouse creating one of Europe's first research teams in Metabolic Engineering in 1990. He has worked on numerous industrially relevant research themes ranging from amino acid and vitamin synthesis, lactic acid bacteria, xenobiotic degradation and more recently many vaccine producing processes, ad established a metabolic modelling approach based on establishing the key metabolic phenomena underpinning their behaviour in fermentation processes. Alongside this academic thrust, he ahs also had a key role in many evaluation committees and presided the French Microbiology Societies Industrial Microbiology Section.